Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Sustained Release Excipients Market, by Route of Administration
1.4.2 North America Sustained Release Excipients Market, by Product
1.4.3 North America Sustained Release Excipients Market, by Technology
1.4.4 North America Sustained Release Excipients Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Sustained Release Excipients Market
Chapter 4. North America Sustained Release Excipients Market by Route of Administration
4.1 North America Oral Market by Country
4.2 North America Transdermal Market by Country
4.3 North America Vaginal Market by Country
4.4 North America Intravenous Market by Country
4.5 North America Ophthalmic Market by Country
4.6 North America Subcutaneous Market by Country
4.7 North America Intramuscular Market by Country
4.8 North America Others Market by Country
Chapter 5. North America Sustained Release Excipients Market by Product
5.1 North America Polymers Market by Country
5.2 North America Minerals Market by Country
5.3 North America Sugars Market by Country
5.4 North America Gelatin & Chitosan Market by Country
5.5 North America Others Market by Country
Chapter 6. North America Sustained Release Excipients Market by Technology
6.1 North America Targeted Delivery Market by Country
6.2 North America Implants Market by Country
6.3 North America Wurster Technique Market by Country
6.4 North America Transdermal Market by Country
6.5 North America Micro Encapsulation Market by Country
6.6 North America Coacervation & Others Market by Country
Chapter 7. North America Sustained Release Excipients Market by Country
7.1 US Sustained Release Excipients Market
7.1.1 US Sustained Release Excipients Market by Route of Administration
7.1.2 US Sustained Release Excipients Market by Product
7.1.3 US Sustained Release Excipients Market by Technology
7.2 Canada Sustained Release Excipients Market
7.2.1 Canada Sustained Release Excipients Market by Route of Administration
7.2.2 Canada Sustained Release Excipients Market by Product
7.2.3 Canada Sustained Release Excipients Market by Technology
7.3 Mexico Sustained Release Excipients Market
7.3.1 Mexico Sustained Release Excipients Market by Route of Administration
7.3.2 Mexico Sustained Release Excipients Market by Product
7.3.3 Mexico Sustained Release Excipients Market by Technology
7.4 Rest of North America Sustained Release Excipients Market
7.4.1 Rest of North America Sustained Release Excipients Market by Route of Administration
7.4.2 Rest of North America Sustained Release Excipients Market by Product
7.4.3 Rest of North America Sustained Release Excipients Market by Technology
Chapter 8. Company Profiles
8.1 BASF SE
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.2 International Flavors & Fragrances, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segment & Regional Analysis
8.2.4 Research & Development Expense
8.3 Ashland Global Holdings Inc. (Pharmachem Laboratories Inc.)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.4 Evonik Industries AG (RAG-Stiftung)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.4.5.3 Acquisition and Mergers:
8.5 Croda International PLC
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.6 Merck Group
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 Pfizer, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional & Segmental Analysis
8.7.4 Research & Development Expense
8.8 Novartis AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 AstraZeneca PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expenses
8.10. Gattefossé
8.10.1 Company Overview
Unique Offerings 